Why have med tech innovators been hesitant to bust through conventional device price ceilings and really go after the money they are worth? And more importantly, what can be done to change the paradigm?
Bayer HealthCare, Edwards Lifesciences, S2N Health, U.K. National Institute for Health & Care Excellence (NICE)
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1yYPaL1
Cap comentari:
Publica un comentari a l'entrada